HBFormer:基于混合注意力机制的单流框架,用于识别人类病毒蛋白质蛋白质相互作用
Liyuan Zhang1, Sicong Wang2, Yadong Wang1
1School of Computer Science and Technology, Harbin Institute of Technology, Harbin, Heilongjiang 150000, China.
Bioinformatics (Oxford, England)
|December 14, 2024
概括
我们开发了HBFormer,这是一个新的计算框架,用于识别人-病毒蛋白-蛋白相互作用 (PPI). 这种单一流的方法提高了预测关键病毒病原机制的准确性和可扩展性.
科学领域:
- 计算生物学是一种计算生物学.
- 病毒学 病毒学
- 生物信息学是一种生物信息学.
背景情况:
- 了解人类病毒蛋白蛋白相互作用 (PPI) 对于阐明病毒病原性至关重要.
- 现有的高通量方法和计算方法在覆盖范围,可扩展性和捕捉复杂交互模式方面存在局限性.
研究的目的:
- 提出一种新的单一流框架,HBFormer,用于准确和可扩展地识别人类病毒PPI.
- 在建模复杂的蛋白质对相互作用时克服双流管道的局限性.
主要方法:
- 开发了HBFormer,这是一个单流框架,集成了混合注意力机制和多式联络功能融合.
- 使用了具有混合注意力的变压器架构,以实现双向信息流和联合功能学习.
- 采用多式联运特征融合策略进行全面的关系建模.
主要成果:
- 在多个人类病毒PPI数据集上,HBFormer实现了卓越的性能.
- 拟议的方法优于其他五种最先进的人类病毒PPI识别技术.
- 废弃研究和可扩展性实验证实了该框架的有效性.
结论:
- HBFormer代表了人类病毒PPI识别计算方法的重大进步.
- 单流框架为预测关键相互作用提供了更好的准确性和可扩展性.
- 这项研究为病毒学研究和药物发现提供了宝贵的工具.
相关概念视频
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
Hybridoma Technology
14.1K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.1K


